Benzinga  Mar 30  Comment 
Xtant Medical Holdings, Inc. (NYSE: XTNT) today announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Xspan™ Laminoplasty Fixation System. The Xspan™ System represents the latest generation of...
Benzinga  Dec 1  Comment 
Xtant Medical Holdings, Inc. (NYSE: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, Inc. received FDA clearance of expanded indications to...


Based in Menlo Park, California and incorporated in the state of Delaware in June, 2002, Xtent, Inc. is a development stage medical device company focused on developing and commercializing its proprietary Custom NX drug eluting stent (DES) Systems to treat coronary artery disease (CAD). The company primarily focuses on its development efforts to create Custom NX DES Systems, which allow a physician to deploy single or multiple stents of customizable lengths with a single device. Xtent's stent systems include the Custom NX 36 which is used to treat single or multiple lesions and the Custom NX 60 that is used to treat one long lesion or multiple smaller lesions with the use of one device. Currently, the company has 108 employees. In May 2004, the company entered into a license agreement with Biosensors International Group Ltd. and Biosensors Europe S.A., obtaining worldwide non-exclusive rights to use Biosensors' drug coating on its products.

On February 1, 2007, Xtent completed its 4.7 million common share initial public offering, raising net proceeds of approximately $68.2 million.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki